Stimulated tumor cells (STC) vaccine induce response in colorectal cancer
A. Italiano et al, J for ImmunoTherapy of Cancer, 2023
http://dx.doi.org/10.1136/jitc-2023-SITC2023.1132 Link to Poster
Brenus’ manufacturing process overpasses the lack of immunogenicity & educates the immune system with visible and multi-specific targets
Selection criteria of starting material (Allogeneic tumor cell lines)
Brenus’ manufacturing process overpasses the lack of antigenicity & educates the immune system with a broad & higher quality range of tumor antigens
